Middletown, DE -- (SBWIRE) -- 09/11/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Peregrine Pharmaceuticals (NASDAQ:PPHM), Servicesource International Inc(NASDAQ:SREV), Exelixis, Inc.(NASDAQ:EXEL), Ceres Inc(NASDAQ:CERE)
Peregrine Pharmaceuticals (NASDAQ:PPHM) was a volume gainer of 2.11 million shares and the average volume of the stock remained 1.02 million shares. The stock opened the session at $1.43 and finished at the end of the day at $1.42 and the stock plunged -6.58%.The market capitalization of the stock remained 220.38 million. The half-yearly trend of the stock remained negative -10.13%. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer. The company?s lead product candidates in development include Bavituximab, a phosphatidylserine (PS) targeting agent that completed Phase IIb second-line non-small cell lung cancer trial for the treatment of solid tumors.
Has PPHM Found The Bottom And Ready To Gain Momentum? Find Out Here
In the preceding trading session, Servicesource International Inc (NASDAQ:SREV) exchanged 1.51 million shares and the average volume remained 1.19 million shares. The stock closed the session at $13.32 with the gain of +0.99%. Tracking three months and 6 months trends, the stock was at of +9.36% and +94.45%, respectively. ServiceSource International, Inc. provides recurring revenue management contracts maintenance, support, and subscription for technology and technology-enabled healthcare, and life sciences companies. The company provides end-to-end management and optimization of the service contract renewals process, including data management, quoting, selling, and service revenue business intelligence.
Will SREV Continue To Move Higher? Find Out Here
Exelixis, Inc.(NASDAQ:EXEL) enhanced +1.73% and its closing price was $5.59. The volume of the stock was 2.01 million shares and the average volume remained 1.52 million shares. Yesterday, the stock traded amid the day price range of $5.46 - $5.64. The market capitalization of the stock remained 1.03 million. The beta of the stock remained 1.94. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib), an inhibitor of multiple receptor tyrosine kinases for the treatment of progressive, metastatic medullary thyroid cancer.
Why Should Investors Buy EXEL After The Recent Gain? Just Go Here and Find Out
Ceres Inc (NASDAQ:CERE) exchanged 2.02 million shares in the previous trading session, and its average trading remained 453,425.00 shares. CERE advanced +17.36% and it closed the trading at $1.42. The market capitalization of the stock remained 35.37 million. YTD trend of the stock was negative -65.78%. Ceres, Inc., an agricultural biotechnology company, develops and sells energy crops to produce renewable biomass feedstocks in North America. The company energy crops include sweet sorghum that complements sugarcane production; high biomass sorghum, suited for the generation of renewable electric power and the creation of cellulosic biofuels.
For How Long CERE’s Gloss will Attract Investors? Find out via this report
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)